CGM in Type 2 Diabetes: Barriers, Adoption & Future Trends

Episode overview:

Only 1 in 5 people with type 2 diabetes on insulin use continuous glucose monitoring (CGM) and for those not on insulin, that number drops to just 5%1. With real-time glucose tracking transforming how patients understand and manage their health, why isn’t CGM more widely used?

In this live episode from the American Diabetes Association (ADA) Conference, Real-Time Real Talk explores the barriers, breakthroughs, and future of diabetes technology. You'll hear why CGM is gaining traction not just for type 1 diabetes, but also in primary care, prediabetes, and even among the glucose-curious.

References

Dexcom, Inc. Dexcom State of Type 2 Report: Access and Attitudes Across the United States. Dexcom, Inc; 2025. Accessed March 25, 2026. View Report

Additional Video Title

Listen on Spotify

Listen on Apple Podcasts

For a deeper dive on this topic, visit GlucoseTech

GlucoseTech

Podcast Clinicians Type 2 NIT Type 2 IIT

Related Content

GlucoseTech

To advance clinical knowledge and patient outcomes by providing evidence-based, clinically relevant CGM education that fits into real world practice.

Built by clinicians and healthcare educators, GlucoseTech delivers practical, evidence-based guidance you can apply immediately—without logins, paywalls, or barriers.

GT Image

Glucose Tech

Expert insights for smarter CGM use

The GlucoseTech Podcast is a trusted educational resource for healthcare professionals seeking the latest insights in CGM technology. Featuring conversations with leading experts, episodes explore emerging evidence, practical patient management strategies, technology innovations, and real-world clinical experiences shaping the future of care. Designed for busy clinicians, GlucoseTech delivers concise, relevant discussions that help translate science into practice. Listen now to stay current on CGM technology.

CGM=continuous glucose monitoring.

MAT-15646